I was going to post that it would be great if the results of our analyses is used to clinically define mild, moderate and severe as a standard of measure in the fight against CV19. Then I realized that this could be derived from your conclusion. To be fair to me, CYDY is my first deep dive into biotech/clinical trials so it takes a little longer. Please don't reply saying this is the same for you.